S-1: Infleqtion Goes Public, Secures $551M for Quantum Tech Scale-Up

Infleqtion, Inc. has completed its business combination and PIPE financing, raising $551.4 million to accelerate its quantum computing, sensing, and software platforms, despite reporting a net loss of $31.8 million in 2025.

Summary

• Infleqtion, Inc. (formerly Churchill Capital Corp X) completed its Business Combination on February 13, 2026, with ColdQuanta, Inc. (Legacy Infleqtion) becoming the accounting acquirer.
• The company raised approximately $551.4 million in gross transaction proceeds, including $424.8 million from the trust account and $126.5 million from a PIPE financing.
• Legacy Infleqtion reported a net loss of $31.8 million for the year ended December 31, 2025, an improvement from a $53.8 million net loss in 2024.
• Total revenue increased by 13% to $32.5 million in 2025, up from $28.8 million in 2024, driven by a $6.3 million increase in service revenue.
• Product revenue decreased by $2.7 million in 2025, primarily due to the expiration of UK government contracts ($6.8 million decrease) and completion of the Quantum Moonshot program in Japan ($3.5 million decrease), partially offset by new US Department of Defense contracts ($6.2 million increase) and growth in European Space Agency and Australian government projects.
• Gross profit increased by 30% to $11.8 million in 2025 from $9.1 million in 2024.
• Research and development expenses rose by 8% to $24.1 million in 2025, while selling, general, and administrative expenses decreased by 7% to $25.3 million.
• The company identified material weaknesses in its internal control over financial reporting, including insufficient accounting personnel for segregation of duties, ineffective risk assessment, inadequate monitoring of its UK subsidiary, and issues with the equity system of record.
• Infleqtion's quantum computing system, Sqale, achieved 12 logical qubits as of December 31, 2025, and demonstrated 99.73% fidelity on its controlled-Z (CZ) gate.
• The company holds 125 issued patents and 108 pending applications as of December 31, 2025, with patents expiring between 2028 and 2044.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing as moderately positive. While the company continues to incur losses and faces significant industry-specific risks, the successful public listing, substantial capital raise, and demonstrated technological advancements in a cutting-edge field provide a strong foundation for future growth and commercialization.

Positives

• Successful completion of the Business Combination and PIPE financing, injecting approximately $551.4 million in gross proceeds.
• Net loss improved significantly to $31.8 million in 2025 from $53.8 million in 2024, indicating progress in financial management.
• Total revenue grew by 13% to $32.5 million in 2025, demonstrating top-line growth.
• Gross profit increased by 30% to $11.8 million in 2025, reflecting improved efficiency or pricing power.
• Full exercise of the underwriters' over-allotment option in the IPO, indicating strong market demand for the initial offering.
• Achieved 12 logical qubits and 99.73% controlled-Z (CZ) gate fidelity on its Sqale quantum computing system, a significant technological milestone in neutral atom quantum computing.
• Secured new government contracts, including a $17.0 million NASA contract modification for a Quantum Gravity Gradiometer, a $2.0 million U.S. Army contract for Linchpin AI, and $6.2 million from the U.S. Department of Energy for energy grid optimization.
• Formed strategic partnerships with industry leaders like Safran Electronics & Defense, Voyager Technologies, Inc., NVIDIA, and SAIC, expanding market access and co-development opportunities.
• Strong international demand for products and services, with non-U.S. revenue representing approximately 29% of total revenue in 2025, including growth from Australian government contracts.

Negatives

• Continued history of operating losses, with an accumulated deficit of $231.1 million as of December 31, 2025.
• Identified material weaknesses in internal control over financial reporting, which could impair the ability to produce timely and accurate financial statements and comply with regulations.
• Product revenue decreased by $2.7 million in 2025, primarily due to the expiration of significant UK government contracts ($6.8 million decrease) and completion of the Quantum Moonshot program in Japan ($3.5 million decrease).
• Incurred $13.5 million in impairment charges for assets and goodwill in 2024 related to the Morton and SiNoptiq acquisitions, indicating a change in strategic direction and loss of expected economic benefits from these investments.
• The quantum technology industry is in its early stages and volatile, with significant research, development, and manufacturing challenges to overcome for commercial viability.
• Reliance on third-party suppliers, including sole-source suppliers, for critical components poses supply chain risks.
• The company will incur increased ongoing costs related to public company regulatory requirements and customary practices.

Risks

• Business involves immature technology, facing significant barriers in producing products that meet desired technical specifications.
• History of operating losses and may not achieve or sustain profitability in the future, with expected higher losses in future periods due to R&D and expansion.
• Failure to adequately fund research and development efforts or use R&D teams effectively could harm technological goals, scalability, and competitiveness.
• Quantum computers may fail to achieve a broad quantum advantage, harming business, financial condition, and future prospects.
• Estimates of market opportunity and forecasts of market growth may prove inaccurate, and alternatives to quantum solutions could reduce market size.
• Inability to scale business quickly enough to meet customer and market demand could adversely affect financial condition and results of operations.
• Failure to manage growth effectively could harm business, results of operations, and financial condition.
• Even if the market grows, the business may fail to grow at similar rates, or at all, due to challenges in scaling operations and customer support.
• Requires substantial additional capital to pursue business objectives, and additional financing may not be available on favorable terms or at all.
• Subject to risks associated with current or future partnerships, including potential non-performance by third parties and increased expenses.
• If quantum solutions are not compatible with industry-standard software and hardware, business could be harmed.
• The quantum technology industry is competitive on a global scale, with larger, well-established tech companies and government-funded research as competitors.
• The quantum technology industry is in its early stages and volatile; slow development, negative publicity, or lack of commercial engagement could harm growth.
• Inability to accurately estimate future supply and demand for products could result in inefficiencies, additional costs, or delays.
• Heavy reliance on sales to certain customers, including the U.S. government, making the company susceptible to changes in government spending and policies.
• Contracts with government entities subject the company to risks including early termination, audits, investigations, sanctions, and penalties.
• Licensing of intellectual property is critical, and termination or non-exclusivity of University Licenses could lead to loss of rights to key technologies.
• Inability to obtain and maintain patent protection or compromise of trade secrets could adversely affect competitive advantage.
• Some intellectual property developed through government-funded research may be subject to federal regulations, limiting exclusive rights or ability to contract with non-U.S. manufacturers.
• Market price of Common Stock may be volatile, causing investment value to decline, especially for growth-oriented companies that entered into SPAC business combinations.
• Provisions in the Certificate of Incorporation requiring exclusive forum in Delaware courts may discourage certain lawsuits.
• Information technology systems or third-party data compromises could lead to regulatory actions, litigation, fines, business disruptions, and reputational harm.
• Use of generative AI tools may pose risks to proprietary software and systems and subject the company to legal liability, including IP infringement claims.
• Unfavorable global macroeconomic, political conditions, and catastrophic events may disrupt business and limit growth.
• Government actions and regulations, such as tariffs and trade protection measures, may adversely impact business and supply chain.
• Acquisitions, divestitures, strategic investments, and partnerships could disrupt business, harm financial condition, and operating results.
• Could suffer future disruptions, outages, defects, and other performance and quality problems with quantum or information systems.
• Success depends on ability to expand sales internationally, exposing the business to risks associated with international operations and foreign currency fluctuations.
• Subject to governmental export and import controls and trade and economic sanctions, which could impair global market competition and subject to liability.
• Subject to stringent and evolving U.S. and foreign laws, regulations, and rules related to data privacy and security, with non-compliance leading to investigations, fines, and reputational harm.
• Subject to U.S. and foreign anti-corruption, anti-bribery, and similar laws, with non-compliance leading to criminal or civil liability.
• Investments may be subject to regulations governing direct and indirect foreign acquisitions of and investments in U.S. businesses (CFIUS and other FDI regimes).
• Claims for indemnification by directors and officers may reduce available funds.
• Public Warrants are redeemable for cash when Common Stock price equals or exceeds $18.00, potentially limiting upside for warrant holders.
• Warrants may expire worthless if not in the money at the time they become exercisable.
• Failure to meet NYSE continued listing requirements could result in delisting.
• Short sellers may engage in manipulative activity, driving down stock price and resulting in regulatory scrutiny.
• Failure to establish and maintain proper and effective internal control over financial reporting could impair accurate financial statements and lead to regulatory actions.
• Incurring significant expenses and administrative burdens as a public company.
• Does not intend to pay cash dividends for the foreseeable future.
• As an emerging growth company, taking advantage of certain exemptions could make securities less attractive to investors and comparison with other public companies difficult.

Future Outlook

Infleqtion aims to lead the global transition of quantum technologies from research to real-world deployment, focusing on operational impact in defense, national security, commercial, and industrial markets. The company plans to scale sensor manufacturing, expand its Sqale quantum computing platform through customer and partner engagements, and broaden the distribution of its Superstaq and CML software offerings. Key technological milestones include targeting 30 logical qubits in 2026 and exceeding 100 logical qubits by 2028, which is considered the threshold for quantum advantage in commercially valuable applications. The company also aims to demonstrate MegaQuOp scale (one million sequential logical operations) by 2028. Infleqtion expects to incur increased ongoing costs as a public company.

Management Comments

• Our vision is to harness the power of quantum to expand human potential.
• Our approach is grounded in an integrated quantum technology platform, from foundational technology to advanced hardware and propriety software, all built on neutral atoms, natures ideal qubits, which enable an adaptable, scalable and high-fidelity path to quantum advantage across multiple applications.
• Today, our high-performance quantum clocks and quantum radio frequency (RF) sensors are already delivering quantum advantage, such as sensing the world with superior precision relative to classical state-of-the-art systems, and unlocking new classes of national security and commercial applications.
• We are among a select group of companies with both operational quantum products and a credible roadmap to scalable, fault-tolerant quantum computing.
• We are targeting a near-term milestone of 100 logical qubits, widely recognized as a threshold for achieving quantum advantage in commercially valuable applications.
• Management believes that our cash and cash equivalents on hand as of December 31, 2025 and the proceeds received at the Closing of the Business Combination will be sufficient to meet our anticipated working capital and capital expenditure requirements for at least 12 to 18 months from the date of this prospectus.

Industry Context

StockSavvy.ai notes that Infleqtion operates in the nascent but rapidly evolving quantum technology industry, characterized by significant R&D challenges and intense global competition from large tech companies (Amazon, Google, IBM, Intel, Microsoft), specialized quantum firms (IonQ, D-Wave, Rigetti), and government-funded initiatives in various countries. Infleqtion's vertically integrated, full-stack platform, leveraging neutral atom architecture for both quantum sensing and computing, positions it uniquely. The company's focus on achieving quantum advantage in practical applications, particularly with its Sqale system's demonstrated high gate fidelity and logical qubit count, aligns with the industry's shift towards fault-tolerant quantum computing. Its diversified revenue model, including product sales, quantum computing as a service, and government R&D contracts, provides a broader base compared to peers focused solely on computing, mitigating some of the inherent risks of an early-stage market.

Comparison to Industry Standards

• Infleqtion's Sqale quantum computer has demonstrated 12 logical qubits as of December 31, 2025, with a target of 100 logical qubits by 2028. This is a key benchmark for achieving quantum advantage in commercially valuable applications, and the company is among a select group demonstrating logical qubits.
• The Sqale system achieved a 99.73% controlled-Z (CZ) gate fidelity, which Infleqtion believes is the highest achieved by any commercial neutral atom company, positioning it favorably against competitors like IonQ (trapped ion), IBM and Rigetti (superconducting circuits), and PsiQuantum (photonic qubits).
• Infleqtion's Tiqker optical atomic clock offers 100 to 1,000 times greater timing performance than conventional atomic clock technologies from incumbent suppliers such as Microchip Technology, SiTime, Safran Electronics & Defense, and Oscilloquartz, particularly in GPS-denied environments.
• The company's neutral atom architecture is highlighted as offering advantages in qubit layout flexibility, connectivity, and scalability without requiring cryogenics, differentiating it from some competitors that rely on extreme cryogenic cooling.
• Infleqtion's CML software is benchmarked to achieve >10x memory savings versus Transformer technology, suggesting a significant performance advantage for AI workloads on classical GPUs, in addition to future quantum computers.

Management Changes

Corporate Governance

Legal Proceedings

• Management is not aware of any pending or threatened litigation that could have a material adverse effect on the company's results of operations, financial condition, or cash flows as of December 31, 2025 and 2024.

Related Party Transactions

• Churchill Sponsor X LLC (the Sponsor) acquired 7,187,500 Class B Ordinary Shares in February 2024 for approximately $0.003 per share, and received additional shares through capitalization in April and May 2025, totaling 10,350,000 Founder Shares. These shares were subject to forfeiture if the over-allotment option was not fully exercised, which it was.
• The Sponsor purchased 300,000 CCX private placement units for $3,000,000 in May 2025.
• CCX agreed to reimburse M. Klein Associates, Inc. (managing member of the Sponsor) $30,000 per month for office space, utilities, and administrative support, which terminated upon the Business Combination closing.
• The Sponsor loaned CCX up to $600,000 to cover IPO expenses via a non-interest bearing promissory note, which was repaid in full at the IPO closing.
• CCX agreed to indemnify the Sponsor and its members/affiliates for claims related to investment opportunities or activities in connection with CCX's affairs.
• Under the Sponsor Agreement (September 8, 2025), 1,500,000 Founder Shares held by the Sponsor became subject to vesting based on post-closing stock price performance ($12.00 per share for 15/180 trading days within five years).
• An Advisory Agreement (September 8, 2025) with M. Klein & Company (affiliate of the Sponsor) became effective upon closing, providing financial advisory, strategic consulting, and business development services for a fixed cash retainer of $250,000 per quarter and expense reimbursement (annual cap $50,000).
• Maverick Capital (affiliated with director David Singer) purchased 2,500,000 shares of Common Stock for $25,000,000 in the PIPE financing.
• Entities affiliated with LCP Quantum Partners (affiliated with former director Tyler Brous) participated in Series A, 2021 Convertible Note, Series B, 2024 SAFE, and Series C financings.
• Entities affiliated with Global Frontier (affiliated with former director Grant Dollens) participated in Series A, 2021 Convertible Note, Series B, 2024 SAFE, and Series C financings.
• Foundry Group Next 2018, L.P. (beneficial owner of >5% capital stock) participated in Series A, 2021 Convertible Note, and Series B financings.
• Entities affiliated with Maverick (affiliated with director David Singer) participated in Series A, 2021 Convertible Note, Series B, 2024 SAFE, and Series C financings.
• Lego Holdings, LP (affiliated with director Catherine Lego) purchased $250,000 in 2024 SAFEs.
• The John R. Kinsella Revocable Living Trust (affiliated with CEO Matthew Kinsella) purchased $200,000 in 2024 SAFEs and 202,593 shares in Series C financing.
• Kristina M. Johnson Revocable Trust (affiliated with director Kristina Johnson) purchased $100,000 in 2024 SAFEs.
• Breakthrough Victoria Pty Ltd (beneficial owner of >5% capital stock) purchased $10,000,000 in 2024 SAFEs and participated in Series B financing.
• The Day Revocable Trust (affiliated with former director Timothy Day) participated in Series A, 2021 Convertible Note, and Series C financings.
• Infleqtion has non-exclusive and exclusive license agreements with the Regents of the University of Colorado, where co-founder Dr. Dana Anderson serves as a professor.
• Infleqtion has an exclusive license agreement with the Wisconsin Alumni Research Foundation (WARF), where its Chief Scientist for Quantum Information serves as a professor.
• Grant Dollens (former director, Interim CFO) received $213,000 in 2025 and $45,000 in 2024 for financial and accounting consulting services.
• DRS Daylight Solutions, Inc. and later Monarch Quantum Inc. (controlled by former director Timothy Day) provided engineering and programming services, with $1.8 million in accounts payable outstanding as of December 31, 2025.
• Clif Anderson (brother of Chief Science Officer Dana Anderson) received $88,000 in legal fees for patent services in 2024 (none in 2025).
• The company purchased laboratory equipment from Microchip Technology Inc. (where director Eric Bjornholt is CFO), with $64,000 in accounts payable outstanding as of December 31, 2025.

Stakeholder Impact

• **Shareholders:** The Business Combination and PIPE financing provide significant capital for growth, but existing shareholders experienced dilution. The stock price may be volatile due to the early stage of the quantum industry and potential short-selling activities. Lock-up restrictions apply to certain shares, and future issuances of debt or equity could further dilute holdings. The exclusive forum provision may limit avenues for certain shareholder lawsuits.
• **Employees:** The company's growth strategy and R&D investments create opportunities for highly skilled employees, particularly physicists and engineers. However, the competitive market for talent and the identified material weaknesses in internal controls highlight challenges in attracting and retaining personnel and ensuring effective operations. Stock-based compensation plans aim to align employee interests with long-term value creation.
• **Customers:** The company's focus on delivering quantum advantage in sensing and computing, along with strategic partnerships, aims to provide advanced solutions for national security, critical infrastructure, and scientific discovery. Delays in technological milestones or product defects could impact customer satisfaction and future orders. Government customers are subject to budgetary constraints and specific contract risks.
• **Suppliers:** Reliance on third-party and sole-source suppliers for critical components means disruptions in the supply chain could impact production and delivery. The company's ability to develop robust supply chains is crucial for scaling.
• **Creditors:** The significant capital raise strengthens the company's liquidity position, reducing immediate concerns about its ability to meet anticipated operating cash needs. However, continued operating losses and future capital requirements mean the company may seek additional debt financing, which could impose covenants and repayment obligations.

Next Steps

• Continue to invest in the design, development, and manufacturing of quantum products.
• Expand research and development activities, particularly towards achieving 100 logical qubits by 2028 and MegaQuOp scale.
• Invest in manufacturing capabilities and build up inventories of components for quantum computers.
• Increase sales and marketing activities and develop distribution infrastructure.
• Increase general and administrative functions to support growing operations as a public company.
• Remediate identified material weaknesses in internal control over financial reporting, with the process potentially extending into 2027.
• Continue to identify and secure suitable business relationship opportunities and strategic partnerships.
• Comply with ongoing public company reporting, governance, and compliance requirements.
• Explore and enter new academic and commercial partnership opportunities complementary to the business.
• Advance the technological roadmap across quantum sensing and quantum computing, including sensor miniaturization, data fusion, and error correction.

Key Dates

Recommendation

Infleqtion's successful public listing and substantial capital infusion are positive developments, providing the necessary funding to advance its cutting-edge quantum technologies. The company's revenue growth and improved net loss in 2025 indicate some operational progress. However, the quantum technology industry remains highly speculative, with significant R&D challenges, intense competition, and an unproven business model for broad commercial advantage. The identified material weaknesses in internal controls also present a notable risk. While the long-term potential is significant, the inherent volatility and early-stage nature of the business warrant a 'hold' recommendation for seasoned investors, suggesting caution and a watchful approach to monitor technological milestones, market adoption, and effective remediation of internal control issues before considering further investment.

Keywords

Quantum Technology, Quantum Computing, Quantum Sensing, Neutral Atoms, SEC Filing, S-1, IPO, PIPE Financing, Business Combination, Infleqtion, ColdQuanta, Sqale, Superstaq, Tiqker, Sqywire, Exaqt, Government Contracts, Defense, Aerospace, National Security, AI, Machine Learning, Financial Results, Net Loss, Revenue Growth, Intellectual Property, Patents, Risk Factors, Internal Controls, NYSE, Warrants